About 58% of patients with psoriasis achieved super responder status with guselkumab, characterised by complete skin ...

Low-grade systemic inflammation is an independent risk factor for psoriasis, especially moderate to severe disease, results ...

Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...

Patients with generalized pustular psoriasis (GPP) experience frequent flares, and treatment alterations of off-label agents ...

The psoriasis pipeline possesses some drugs in mid- and late-stage development to be approved in the near future. The emerging landscape holds a diverse range of therapeutic alternatives for treatment ...

Icotrokinra achieved 75% complete skin clearance in adolescents with moderate to severe plaque psoriasis by week 24, indicating significant efficacy. The ICONIC-LEAD trial is the first to evaluate ...

Many people who have psoriasis will experience the telltale sign of itchiness or burning. But for people with differing skin tones, that’s where the similarities may end. The symptoms of ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...

The company plans to submit a BLA for Imsidolimab in generalized pustular psoriasis sometime in 2025. This product candidate, which has two phase 3 trials under its belt, has been partnered with ...

Art Garfunkel is breaking the sound of silence around his experience with plaque psoriasis. The singer, one half of the folk-rock duo Simon & Garfunkel, has teamed with Sun Pharma to discuss how ...

Please provide your email address to receive an email when new articles are posted on . The mean annualized flare rate per patient per year was 0.91, with a mean time of 5.9 months between flares.

Spesolimab, an IL-36 receptor antagonist approved for generalized pustular psoriasis, has shown promise in the treatment of PG, as evidenced by several case reports and our patient’s response (16, 17) ...